야생동물 건강 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global wildlife health market size is expected to reach USD 8.02 Billion in 2034 from USD 3.18 Billion in 2025, growing at a CAGR of 10.82 during 2026-2034.This market is expanding steadily due to increasing awareness regarding biodiversity conservation, zoonotic disease prevention, and ecosystem sustainability. Governments, conservation agencies, and research organizations are investing in wildlife disease surveillance, veterinary care, and habitat protection to safeguard animal populations. Growing recognition of the connection between wildlife health, environmental stability, and public health is further supporting industry growth.

Advancements in wildlife diagnostics, disease monitoring technologies, molecular testing, and remote tracking systems are improving the detection and management of infectious diseases among wild animal populations. Conservation programs are increasingly utilizing digital health monitoring tools and advanced veterinary treatments to improve rehabilitation outcomes. Collaborative research initiatives are also strengthening disease prevention strategies across global ecosystems.

Future prospects remain promising as investments increase in wildlife conservation, environmental monitoring, and advanced veterinary research. Artificial intelligence, genomic analysis, and remote sensing technologies are expected to improve disease surveillance and ecological management. Continued global focus on biodiversity protection and One Health initiatives will generate substantial opportunities for long-term industry development.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Animal Type

• Mammals
• Birds
• Fish
• Reptiles
• Amphibians

By Product

• Medicine
• Equipment and Consumables

By Route of Administration

• Oral
• Injectable
• Other Routes of Administration

By End User

• Zoos
• Wildlife Sanctuaries
• Wildlife Rescue and Rehab Centers
• Other End Users

COMPANIES PROFILED

• Merck & Co. Inc. (MSD Animal Health), Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Orion Corporation, Virbac SA, Ceva Sante Animale, Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Huvepharma EOOD, Vetoquinol SA, Indian Immunologicals Limited

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL WILDLIFE HEALTH MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Animal Type
• 4.2. Mammals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Birds Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Fish Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Reptiles Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Amphibians Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL WILDLIFE HEALTH MARKET: BY PRODUCT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Product
• 5.2. Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Equipment and Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL WILDLIFE HEALTH MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Route Of Administration
• 6.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other Routes of Administration Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL WILDLIFE HEALTH MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Zoos Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Wildlife Sanctuaries Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Wildlife Rescue and Rehab Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL WILDLIFE HEALTH MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Animal Type
  • 8.2.2 By Product
  • 8.2.3 By Route Of Administration
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Animal Type
  • 8.3.2 By Product
  • 8.3.3 By Route Of Administration
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Animal Type
  • 8.4.2 By Product
  • 8.4.3 By Route Of Administration
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Animal Type
  • 8.5.2 By Product
  • 8.5.3 By Route Of Administration
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Animal Type
  • 8.6.2 By Product
  • 8.6.3 By Route Of Administration
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL WILDLIFE HEALTH INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Merck & Co. Inc. (MSD Animal Health)
  • 10.2.2 Boehringer Ingelheim International GmbH
  • 10.2.3 Elanco Animal Health Incorporated
  • 10.2.4 IDEXX Laboratories Inc
  • 10.2.5 Orion Corporation
  • 10.2.6 Virbac SA
  • 10.2.7 Ceva Sante Animale
  • 10.2.8 Phibro Animal Health Corporation
  • 10.2.9 Dechra Pharmaceuticals PLC
  • 10.2.10 Huvepharma EOOD
  • 10.2.11 Vetoquinol SA
  • 10.2.12 Indian Immunologicals Limited